Home

Stanley Tennant

CIK 1526214 · last filed 2018-06-13

Stanley Tennant is a corporate insider who has filed 22 SEC Form 4 insider transactions across 3 companies since 2012. The most recent filing shows the insider bought $8.0K of TROV on Jun 13, 2018. Across all open-market trades the lifetime net is +$242.3K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

22

Lifetime Open-Market Net

$242.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Cardiff Oncology, Inc. (TROV) Delisted Director 28,839 — — $10.2K 8 2018-06-13
Cardiff Oncology, Inc. (TROVW) Delisted Director 217,728 — — $232.0K 11 2017-01-05
Oak Ridge Financial Services, Inc. (BKOR) Delisted Director 33,385 — — $0 1 2013-01-02

Recent Filings

22 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-06-13 Cardiff Oncology, Inc. (TROV) Delisted Buy (P) +10,000 $8.0K EDGAR
2018-06-11 Cardiff Oncology, Inc. (TROV) Delisted Buy (P) +10,000 $8.0K EDGAR
2018-01-25 Cardiff Oncology, Inc. (TROV) Delisted Grant (A) — $0 EDGAR
2018-01-04 Cardiff Oncology, Inc. (TROV) Delisted Exer (M) +16,667 $0 EDGAR
2018-01-04 Cardiff Oncology, Inc. (TROV) Delisted Exer (M) +16,667 $0 EDGAR
2017-10-05 Cardiff Oncology, Inc. (TROV) Delisted Grant (A) — $0 EDGAR
2017-09-06 Cardiff Oncology, Inc. (TROV) Delisted Sell (S) −8,334 -$5.8K EDGAR
2017-09-06 Cardiff Oncology, Inc. (TROV) Delisted Exer (M) +8,484 $0 EDGAR
2017-01-05 Cardiff Oncology, Inc. (TROVW) Delisted Grant (A) — $0 EDGAR
2017-01-04 Cardiff Oncology, Inc. (TROVW) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 22
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.